Market Cap 1.29B
Revenue (ttm) 1.23B
Net Income (ttm) -87.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 27.16
Profit Margin -7.11%
Debt to Equity Ratio 0.00
Volume 21,545
Avg Vol 234,978
Day's Range N/A - N/A
Shares Out 63.29M
Stochastic %K 92%
Beta N/A
Analysts Strong Sell
Price Target $28.00

Company Profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its da...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 404 810 0089
Address:
300 Galleria Parkway SE, Suite 800, Atlanta, United States
DonCorleone77
DonCorleone77 May. 23 at 10:19 AM
$GRDN Guardian Pharmacy 7.5M share Secondary priced at $21.00 The deal priced below last closing price of $22.58. Raymond James is acting as lead book running manager for the offering.
0 · Reply
briefingcom
briefingcom May. 21 at 12:04 PM
Gapping down: $WOLF -62.3% $VFC -13% $CRI -7.5% $GRDN -7.5% $CTRI -7.2%
0 · Reply
DonCorleone77
DonCorleone77 May. 20 at 8:34 PM
$GRDN Guardian Pharmacy announces 7.5M Class A common stock offering Guardian Pharmacy Services announced the launch of a proposed underwritten public offering of 7.5M shares of its Class A common stock, consisting of 6.06M shares being offered by certain selling stockholders and 1.44M newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction. Guardian will not receive any proceeds from the offering of shares by the selling stockholders in the offering. Raymond James is acting as lead bookrunning manager of the offering and as representative of the underwriters for the proposed offering. Stephens Inc. and Truist Securities are acting as joint bookrunning managers for the offering.
0 · Reply
PenkeTrading
PenkeTrading May. 3 at 2:30 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Guardian Pharmacy Services, Inc.. Is that bullish or bearish? $GRDN #Guardian #RsiOverbought #NYSE
0 · Reply
jParkz
jParkz Apr. 30 at 8:30 PM
$GRDN News Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call https://marketwirenews.com/news-releases/guardian-pharmacy-services-inc-to-report-first-quart-7216220391792817.html $GRDN
0 · Reply
JFDI
JFDI Apr. 25 at 12:37 AM
$GRDN IPO
0 · Reply
Doozio
Doozio Apr. 17 at 11:24 PM
If YO can’t $SII whuts going on? like n subscribe! then let’s get going on that $GRND discount code ends 2mro! Water that $GRDN Bums.
0 · Reply
IN0V8
IN0V8 Apr. 11 at 3:34 PM
$GRDN Truist Securities raises PT to $25 from $24
0 · Reply
JarvisFlow
JarvisFlow Apr. 11 at 1:00 PM
Truist Securities has updated their rating for Guardian Pharmacy Service ( $GRDN ) to Buy with a price target of 25.
0 · Reply
Doozio
Doozio Apr. 10 at 2:36 PM
$GRND appears like a wen not if 🐒🍌🧠 ⏰♾️. So keep $GRDN
2 · Reply
Latest News on GRDN
U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

Sep 28, 2024, 1:00 AM EDT - 9 months ago

U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

BIOA BKV FLX FVR PC SARO


Guardian Pharmacy shares rise 3% in lukewarm NYSE debut

Sep 26, 2024, 10:50 AM EDT - 9 months ago

Guardian Pharmacy shares rise 3% in lukewarm NYSE debut


Healthcare firm Guardian Pharmacy raises $112 mln in US IPO

Sep 25, 2024, 9:45 PM EDT - 9 months ago

Healthcare firm Guardian Pharmacy raises $112 mln in US IPO


Guardian Pharmacy Services' IPO Valuation Looks Pricey

Sep 18, 2024, 11:46 AM EDT - 10 months ago

Guardian Pharmacy Services' IPO Valuation Looks Pricey


Guardian Pharmacy targets up to $974 mln valuation in US IPO

Sep 16, 2024, 12:33 PM EDT - 10 months ago

Guardian Pharmacy targets up to $974 mln valuation in US IPO


Guardian Pharmacy Services Launches U.S. IPO Effort

Oct 4, 2023, 1:16 PM EDT - 1 year ago

Guardian Pharmacy Services Launches U.S. IPO Effort


DonCorleone77
DonCorleone77 May. 23 at 10:19 AM
$GRDN Guardian Pharmacy 7.5M share Secondary priced at $21.00 The deal priced below last closing price of $22.58. Raymond James is acting as lead book running manager for the offering.
0 · Reply
briefingcom
briefingcom May. 21 at 12:04 PM
Gapping down: $WOLF -62.3% $VFC -13% $CRI -7.5% $GRDN -7.5% $CTRI -7.2%
0 · Reply
DonCorleone77
DonCorleone77 May. 20 at 8:34 PM
$GRDN Guardian Pharmacy announces 7.5M Class A common stock offering Guardian Pharmacy Services announced the launch of a proposed underwritten public offering of 7.5M shares of its Class A common stock, consisting of 6.06M shares being offered by certain selling stockholders and 1.44M newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction. Guardian will not receive any proceeds from the offering of shares by the selling stockholders in the offering. Raymond James is acting as lead bookrunning manager of the offering and as representative of the underwriters for the proposed offering. Stephens Inc. and Truist Securities are acting as joint bookrunning managers for the offering.
0 · Reply
PenkeTrading
PenkeTrading May. 3 at 2:30 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Guardian Pharmacy Services, Inc.. Is that bullish or bearish? $GRDN #Guardian #RsiOverbought #NYSE
0 · Reply
jParkz
jParkz Apr. 30 at 8:30 PM
$GRDN News Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call https://marketwirenews.com/news-releases/guardian-pharmacy-services-inc-to-report-first-quart-7216220391792817.html $GRDN
0 · Reply
JFDI
JFDI Apr. 25 at 12:37 AM
$GRDN IPO
0 · Reply
Doozio
Doozio Apr. 17 at 11:24 PM
If YO can’t $SII whuts going on? like n subscribe! then let’s get going on that $GRND discount code ends 2mro! Water that $GRDN Bums.
0 · Reply
IN0V8
IN0V8 Apr. 11 at 3:34 PM
$GRDN Truist Securities raises PT to $25 from $24
0 · Reply
JarvisFlow
JarvisFlow Apr. 11 at 1:00 PM
Truist Securities has updated their rating for Guardian Pharmacy Service ( $GRDN ) to Buy with a price target of 25.
0 · Reply
Doozio
Doozio Apr. 10 at 2:36 PM
$GRND appears like a wen not if 🐒🍌🧠 ⏰♾️. So keep $GRDN
2 · Reply
Doozio
Doozio Apr. 9 at 10:30 PM
$GRDN $GRND chop chop huckleberries scrabble bag it! N 🖕da 🐑 bums! There is only ☝️…..
0 · Reply
DonCorleone77
DonCorleone77 Mar. 26 at 8:06 PM
$GRDN Guardian Pharmacy sees FY25 revenue $1.33B-$1.35B, consensus $1.34B Sees FY25 adjusted EBITDA $97M-$101M vs. $90.8M last year.
0 · Reply
DonCorleone77
DonCorleone77 Mar. 26 at 8:05 PM
$GRDN Guardian Pharmacy reports Q4 EPS 19c, consensus 22c Reports Q4 revenue $338.6M, consensus $332.8M. Reports Q4: Resident Count of 186,000 at the end of the quarter, an increase of 14% year-over-year and up from 180,000 in the prior quarter, attributable to organic growth and the acquisitions. "We're proud to report that we ended the year on a strong note, exceeding our expectations for the fourth quarter and year ended December 31, 2024. The outperformance was driven by strong organic growth, acquisitions, and the new benefit of the seasonal trend related to conducting vaccine clinics in certain long-term care facilities we serve. Looking ahead, we enter 2025 well-positioned for success and we remain committed to continuing to meet the needs of all of the residents we serve," said Fred Burke, President & CEO of Guardian.
0 · Reply
DonCorleone77
DonCorleone77 Mar. 3 at 11:40 AM
$GRDN Guardian Pharmacy sees FY24 revenue ~$1.228B, consensus $1.21B FY24 revenue is expected to be approximately $1.228B, an expected increase of approximately 17.4% year-over-year, driven by organic growth of the business and the previously announced acquisitions of Heartland Pharmacy and Freedom Pharmacy, completed on April 1, 2024, and November 1, 2024, respectively. Revenue was also positively impacted by an increase in flu and COVID-19 vaccinations administered through clinics in certain long-term care facilities we serve. Net Income (loss) is expected to be between ($71.8M)-($72.8M), an expected decrease between $109.5M-$110.5M year-over-year, primarily attributable to approximately $131.5M of share-based compensation expense, the majority of which is associated with our Corporate Reorganization and initial public offering. This also resulted in a net loss per share for the year. Adjusted EBITDA is expected to be approximately $90.8M, an expected increase of approximately 19.2% year-over-year.
0 · Reply
DonCorleone77
DonCorleone77 Mar. 3 at 11:38 AM
$GRDN Guardian Pharmacy sees FY25 revenue $1.33B-$1.35B, consensus $1.33B Sees FY25 adjusted EBITDA $97M-$101M.
0 · Reply
DonCorleone77
DonCorleone77 Mar. 3 at 11:37 AM
$GRDN Guardian Pharmacy sees Q4 revenue ~$338.6M, consensus $320.52M Q4 Net Income is expected to be between $10.1M-$11.1M, an expected decrease between $3.5M-$4.5M year-over-year, primarily attributable to expected income tax provision expense between $5M-$6M. Adjusted EBITDA is expected to be approximately $25.9M, an expected increase of approximately 30.3% year-over-year. "We're proud to report that we ended the year on a strong note, exceeding our expectations for the fourth quarter and year ended December 31, 2024. The outperformance was driven by strong organic growth, acquisitions, and the new benefit of the seasonal trend related to conducting vaccine clinics in certain long-term care facilities we serve. Looking ahead, we enter 2025 well-positioned for success and we remain committed to meeting the needs of all of the residents we serve," said Fred Burke, President & CEO of Guardian.
0 · Reply
FeatherWeight
FeatherWeight Dec. 9 at 5:41 AM
$SEPN Alert set, want to get a starter going here. If it could then move up, offer tight price action into the $27-28 range on low volume, would look to buy even more. Then have a breakout move into new high ground like $GRDN which had really clean IPO base set up, price swings got tight from left to right to single digit(≈8%), volume stayed low(meaning supply wasn’t coming to market) and broke out on cue. Nice move upwards since 🙌🏼 congrats long!
0 · Reply
movershakertaker
movershakertaker Nov. 25 at 5:36 PM
0 · Reply
IN0V8
IN0V8 Nov. 14 at 2:13 PM
$GRDN Opportunity Raymond James raises target to $25 from $21 Stephens raises target price to $23 from $21
0 · Reply
Doozio
Doozio Nov. 8 at 1:55 PM
FRYdays in da FUTUre of 🧠⏰ on that $GRDN NOW n gonna keep $GRND ing INTA 🧠⏰♾️
0 · Reply
Doozio
Doozio Nov. 4 at 4:40 PM
$GRDN much easier bring green during 🧠⏰♾️
0 · Reply